Stem cell transplantation in living donor renal transplantation for minimization of immunosuppression

Transplantation

Volumn 94, Issue 8, 2012, Pages 845-850

  Vanikar, Aruna V ^a   Trivedi, Hargovind L ^b  

^a G R Doshi and K M Mehta Institute of Kidney Diseases and Research Centre IKDRC   (India)

^b Dr HL Trivedi Institute of Transplantation Sciences ITS   (India)

Author keywords

Acute rejection; Clonal deletion; Hematopoietic stem cells; Mesenchymal stem cells; Minimization of immunosuppression; Renal transplantation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MEPREDNISONE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DRUG DOSE REDUCTION; FEMALE; GRAFT SURVIVAL; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LIVING DONOR; LOW DRUG DOSE; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONMYELOABLATIVE CONDITIONING; OPEN STUDY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT;

ADULT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; LIVING DONORS; LYMPHATIC IRRADIATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED;

EID: 84868201531     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182664000     Document Type: Article

References (38)

1. Suthanthiran M. Transplantation tolerance: fooling mother nature. Proc Natl Acad Sci 1996; 93: 12072.
2. Auchincloss H Jr. In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance. Am J Transplant 2001; 1: 6.
3. Thomson AW, Lu L. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 1999; 68: 1.
4. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantationVfriend or foe? Immunity 2001; 14: 357.
5. Tomasoni S, Azzollini N, Casiraghi F, et al. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 2000; 11: 747.
6. Kirk AD. Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories. Crit Rev Immunol 1999; 19: 349.
7. Trivedi HL, Vanikar AV, Gumber MR, et al. Abrogation of antibodies improves outcome of renal transplantation. Transplant Proc 2012; 44: 241.
8. Spitzer TR, Delmonico F, Tolkoff-Rubin N, et al. Combined histocompatibility leukocyte antigen matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480.
9. Kawai T, Cosimi B, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
10. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 2012; 12: 1133.
11. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without gvhd or engraftment syndrome in hla-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Translational Med 2012; 4(124): 124ra28.
12. Ryan JM, Barry FP, Murphy JM, et al. Mesenchymal stem cells avoid allogeneic rejection. J Inflammation 2005; 2: 8.
13. Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307.
14. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42.
15. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815.
16. Vanikar AV, Goplani KR, Trivedi HL, et al. Operational tolerance in living-related renal transplantation: a single-center experience. Transplant Proc 2011; 43(5): 1551.
17. Friedenstein AJP, Petrokova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphology 1966; 16: 381.
18. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143.
19. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41.
20. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci 2001; 938: 231.
21. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417.
22. Oluwole OO, Depaz HA, Gopinathan R, et al. Indirect allorecognition in acquired thymic tolerance induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 2001; 50: 1546.
23. Koc ON, Day J, Nieder M, et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215.
24. Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389.
25. Zhang W, Ge W, Li C, et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 2004; 13: 263.
26. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005; 105: 2214.
27. Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120.
28. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815.
29. Trivedi H, Vanikar A, Vakil J, et al. A strategy to achieve donorspecific hyporesponsiveness in cadaver renal allograft recipients by donor haematopoietic stem cell transplantation in to the thymus and periphery. Nephrol Dial Transplant 2004; 19: 2374.
30. Trivedi HL, Vanikar AV, Vakil J, et al. Allogeneic hematopoietic stem cell transplantation, mixed chimerism and tolerance in living related donor renal allograft recipients. Transplant Proc 2005; 37: 737.
31. Vanikar AV, Trivedi HL, Feroze A, et al. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness. Int Urol Nephrol 2011; 43: 225.
32. Trivedi HL, Kaneku H, Terasaki PI, et al. Clonal deletion using total lymphoid irradiation with no maintenance immunosuppression in renal allograft recipients. Clin Transpl 2009; 265.
33. Trivedi HL, Terasaki PI, Feroz A, et al. Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients. Transplantation 2010; 90: 221.
34. Abraham G, John GT, Sunil S, et al. Evolution of renal transplantation in India over the last four decades. NDT Plus 2010; 3: 203.
35. Gumber MR, Kute VB, Goplani KR, et al. Deceased donor organ transplantation: a single center experience. Indian J Nephrol 2011; 21: 182.
36. Jha V. Post-transplant infections: an ounce of prevention. Indian J Nephrol 2010; 20: 171.
37. Jha V, Chugh KS. Posttransplant infections in the tropical countries. Artif Organs 2002; 26: 770.
38. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: update and future directions. Am J Transplant 2008; 8: 753.